TreedhaTreedha — Earth to Excellence
Journal/Purity & Safety

Mandatory GRAS Notification: Improving Ingredient Transparency

The FDA’s proposed transition from voluntary self-affirmation to mandatory GRAS notification marks a critical shift toward greater transparency and rigorous safety documentation in the global food supply chain.

Treedha Editorial · 22 August 2026 · 5 min læsetid

Close-up of raw, vibrant spices being sorted by hand in a rustic, light-filled facility at origin.

The U.S. Food and Drug Administration (FDA) has proposed a rule that would fundamentally reform the Generally Recognized as Safe (GRAS) framework. If finalized, this proposal would replace the long-standing voluntary 'self-GRAS' process with a mandatory notification requirement for all substances entering the food supply. This shift prioritizes public health oversight by compelling companies to provide formal, scientifically documented evidence to the agency for review, ending decades of independent, agency-unseen safety determinations. For importers and distributors, this represents a move toward institutionalised transparency. Mandatory GRAS notification will standardise the safety verification of ingredients, helping firms align their supply chain practices with evolving global standards.

Understanding the Mandatory GRAS Notification Proposal

For nearly seventy years, the GRAS provision—originally established under the 1958 Food Additives Amendment—allowed manufacturers to determine an ingredient's safety through internal review, provided it was supported by expert consensus. This system was designed to acknowledge that substances with a history of safe use in food, or those based on widespread scientific evidence, did not require the protracted pre-market approval process reserved for new food additives. However, the proposed rule, outlined in FDA Docket FDA-2025-N-3262, seeks to modernize this framework to better reflect current food science complexities and consumer safety expectations.

The core of the proposal mandates that all new safety findings be submitted to the agency for formal review. This shift aims to provide the FDA with a comprehensive, centralized inventory of substances, thereby enhancing their regulatory visibility and reducing the potential for safety gaps within the food supply. The agency has indicated that a streamlined, time-limited process will be available for substances already on the market, facilitating a transition period for existing portfolios. This is not merely a paperwork exercise; it represents a cultural shift toward proactive, rather than reactive, safety management.

At Treedha, we view this transition as a validation of our commitment to rigorous, independent testing. By moving away from self-attestation toward agency-reviewed documentation, the industry gains a clearer benchmark for safety. This alignment is essential for premium spice and pantry supply chains, where the purity of the source is paramount. We invite partners to explore our full provenance approach, which serves to bridge the gap between origin-based quality and the increasing demand for regulatory clarity. By ensuring every batch is mapped to its geographical and agricultural roots, we are already positioned to meet the documentation demands inherent in this new regulatory climate.

Impact on Supply Chain Integrity and Compliance

The implications for private-label and food-brand buyers are significant. The move requires an immediate audit of any proprietary spice blends, extracts, or processing aids to ensure their safety status remains in alignment with forthcoming FDA mandates. Documentation must now transition from internal, 'self-affirmed' dossiers—which often resided solely in the cabinets of manufacturers—to external, agency-verified submissions. This reduction in the use of 'hidden' safety profiles is a net positive for premium distributors who manage high-quality spices and pantry staples.

When a supply chain relies on 'hidden' or self-determined GRAS status, the liability rests entirely on the distributor. Under the new proposal, the burden of proof shifts. Distributors must ensure that the raw materials they procure—whether complex spice blends or specific botanical extracts—possess the necessary FDA-verified safety credentials. This eliminates the uncertainty that has plagued niche ingredient sourcing, where small-scale producers often relied on informal safety assessments that lack the robustness of modern toxicological standards.

Maintaining rigorous supply chain integrity is not merely a legal requirement; it is a component of brand trust. As regulators tighten their scrutiny, reliance on full, lab-tested data becomes the definitive indicator of quality. Our commitment to being ETO-free and lab-tested to strict EU and US limits ensures that our partners operate with the highest level of regulatory security. By focusing on direct sourcing, we maintain complete control over the safety profiles of our products, from harvest to the final pack. We believe that transparency is the most effective form of risk mitigation.

Comparing GRAS Frameworks and Modern Standards

To navigate the evolving landscape, stakeholders must differentiate between legacy systems and the proposed regulatory environment. While the current voluntary GRAS process allows for rapid innovation, it lacks the oversight necessary for complex, highly processed additives. The following comparison illustrates the transition from the legacy "self-determined" era to the proposed era of institutionalised accountability.

FeatureCurrent Voluntary GRASProposed Mandatory GRASGlobal Manufacturing (GFM) Best Practice
Regulatory FilingOptionalMandatoryMandatory/Audited
OversightSelf-determinedFDA-reviewedExternal/Third-Party Certified
TransparencyLimitedCentralised InventoryFull Traceability
Scientific BurdenInternal consensusDocumented agency submissionPeer-reviewed toxicological data
ImplementationMarket-drivenRisk-managedQuality-assured

The integration of Global Manufacturing (GFM) best practices—highlighted in the table above—serves as a template for how companies can stay ahead of these regulatory curves. While the FDA proposal brings the U.S. closer to global standards, companies that already operate with rigorous third-party auditing and high-transparency sourcing will find the transition to mandatory notification to be a straightforward evolution of their existing quality management systems.

For the premium food sector, the "mandatory" shift is an opportunity to distance the industry from low-quality, opaque sourcing practices. When a buyer procures turmeric powder or blends, they are not just buying an ingredient; they are buying the safety profile attached to it. Under the new rule, the 'paper trail' becomes as vital as the product itself.

We encourage all food-brand buyers to proactively review their current ingredient specifications. Understanding the status of each additive is now a core risk-mitigation strategy. If an ingredient in your supply chain currently relies on a self-affirmed status that lacks public documentation, it is time to pivot toward partners who provide laboratory-verified, transparent, and compliant documentation. Whether you are sourcing raw spices or complex pantry staples, maintaining documented evidence of compliance is the foundation of future-proof procurement. By aligning your business with these higher standards today, you safeguard your brand's reputation and ensure a seamless transition into the era of mandatory FDA regulatory oversight.

Frequently asked questions

What does the new FDA GRAS proposal change?

The proposal mandates that all substances classified as Generally Recognized as Safe (GRAS) must be formally notified to the FDA for agency review, effectively ending the previous system of voluntary self-affirmation.

How does this affect food importers?

Importers must shift from internal safety documentation to agency-verified compliance. This requires an audit of proprietary additives, blends, and processing aids to ensure they meet the new submission requirements.

Is there a grace period for existing ingredients?

Yes, the FDA has proposed a 'time-limited, streamlined' submission process for substances already in use to assist companies in transitioning their existing inventories to the new mandatory framework.

Why is this shift occurring now?

The shift aims to improve the FDA's visibility into the food supply, ensure greater transparency for consumers, and address longstanding concerns regarding the lack of agency oversight in independent safety determinations.

Sources